InvestorsHub Logo
Followers 4
Posts 422
Boards Moderated 0
Alias Born 06/01/2017

Re: north40000 post# 6490

Tuesday, 09/19/2017 5:27:38 PM

Tuesday, September 19, 2017 5:27:38 PM

Post# of 8022
This is exacting what I'm referring to ...


Speaking of Amgen, were we aware of this PR? Is CYTK potential competition?:
"CYTOKINETICS ANNOUNCES DOSING OF FIRST PATIENT IN JAPAN IN GALACTIC-HF, PHASE 3 CLINICAL TRIAL OF OMECAMTIV MECARBIL IN PATIENTS WITH HEART FAILURE



According to their website, they have 1 or 2 products in review (with different version,), and already at 780M market cap.

https://cytokinetics.com/pipeline/

If $VCEL was up for sale for hundreds of million or even a billion, AMGN and others would have gobbled it by now. I'm positive, our CEO is sure that this will be many folds very soon...

If this works outs, as I'm envisioning it; I feel, that I may never be in a stock that I can invest in it with such confident, and I be able to make millions out of it. It's like investing in Telsa many years ago.

Soon we will all be wishing, just if we did buy few more shares...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VCEL News